- Latest news▼
-
16:41, April 15 Cell: in carriers of defective BRCA2 gene, sugar consumption increases cancer risk
-
15:04, April 15 305 cases of measles recorded in Armenia so far in 2024
-
14:38, April 15 Food and Environmental Virology: tea contributes to effective coronavirus control
-
12:41, April 15 Daily Mail: vitamin A, B3 and E supplements can be dangerous
-
10:56, April 15 Diabetes Care: evening physical activity is good for the heart
-
08:27, April 15 Women are more susceptible to blood loss and death during bypass surgery than men, researchers say
-
18:42, April 13 WHO: Nigeria pioneers revolutionary meningitis vaccine
-
16:43, April 13 One-third of women experience menstruation-related migraines, most often during premenopause - study
-
14:37, April 12 Pediatrics: Hypoglossal nerve stimulation implant helps with sleep apnea
-
12:13, April 12 Health minister: Simulation educational center will be created, assisted reproductive technology capacity will increase in Armenia
-
17:03, April 11 BMJ: antidepressant injection 4 times reduced risk of severe postpartum depression
-
11:35, April 11 Health minister: Number of hard-to-reach medical services within state funding scope increased in Armenia in 2023
-
16:10, April 10 Breathing therapy, which is so popular in the world, is starting to spread in Armenia
-
21:36, April 9 Frontiers: sun exposure destroys skin microbiome
-
17:24, April 9 EClinicalMedicine: depression increases the lethality of breast cancer
All materials
Scientists propose new approach to hepatitis B treatment
Russian scientists have developed a unique technology for the treatment of chronic hepatitis B.
According to RIA Novosti, for the first time in the world a prototype of a pharmaceutical substance (active substance) has been developed based on the technology of site-directed nuclease proteins capable of destroying over 99% of viral genomes in infected cells within a few days.
The main feature of the new active ingredient is its non-toxicity and safety. On its basis, it is planned to create a full-fledged drug in the future.
Today in the world there are more than 250 million people with chronic hepatitis B, the death rate exceeds a million people a year. At the same time, it is not yet possible to completely recover from it.
Follow NEWS.am Medicine on Facebook and Twitter
- Video
- Event calendar
- Archive
- Most read
month
week
day
- Breathing therapy, which is so popular in the world, is starting to spread in Armenia 1772
- Frontiers: sun exposure destroys skin microbiome 1335
- EClinicalMedicine: depression increases the lethality of breast cancer 1334
- FEV: Black tea inactivates SARS-CoV-2 in saliva 1332
- BMJ: antidepressant injection 4 times reduced risk of severe postpartum depression 1095
- Health minister: Number of hard-to-reach medical services within state funding scope increased in Armenia in 2023 1061
- Pediatrics: Hypoglossal nerve stimulation implant helps with sleep apnea 958
- Health minister: Simulation educational center will be created, assisted reproductive technology capacity will increase in Armenia 925
- WHO: Nigeria pioneers revolutionary meningitis vaccine 757
- One-third of women experience menstruation-related migraines, most often during premenopause - study 737
- Women are more susceptible to blood loss and death during bypass surgery than men, researchers say 390
- Food and Environmental Virology: tea contributes to effective coronavirus control 374
- Daily Mail: vitamin A, B3 and E supplements can be dangerous 372
- Diabetes Care: evening physical activity is good for the heart 341
- 305 cases of measles recorded in Armenia so far in 2024 325
- Find us on Facebook
- Poll